Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-10-27

FDA Approved: ARSENIC TRIOXIDE — Supplemental Application (Nexus Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for arsenic trioxide filed by Nexus Pharmaceuticals LLC, typically involving labeling or manufacturing changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arsenic Trioxide (arsenic trioxide)

Snippet

SUPPL AP for ARSENIC TRIOXIDE (ARSENIC TRIOXIDE)